Cervical Adenosquamous Carcinoma — Trials

Cervical Adenosquamous Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 4
Ph III recruiting: 1
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00924066	Ixabepilone to Treat Cervical Cancer	terminated	Phase 2	41	National Cancer Institute (NCI)NIH	1	Nov 21, 2019	clinicaltrials
NCT02868892	A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas	terminated	Phase 2	6	Western Regional Medical CenterOTHER	1	Nov 2, 2018	clinicaltrials